The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Open accessAbstract
Multidrug-resistant (MDR) strains of Mycobacterium tuberculosis have emerged worldwide. In many countries and regions, these resistant strains constitute a serious threat to the efficacy of tuberculosis control programs. An important element in gaining control of this epidemic is developing an understanding of the molecular basis of resistance to the most important antituberculosis drugs: isoniazid, rifampin, and pyrazinamide. On the basis of this information, more exacting laboratory testing, and ultimately more appropriate and timely treatment regimens, can be developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Scorpio, A., & Zhang, Y. (1996) · Nature Medicine · doi:10.1038/nm0696-662 · Cited by 726
Mycobacterial cell wall: Structure and role in natural resistance to antibiotics
Jarlier, V (1994) · FEMS Microbiology Letters · doi:10.1016/0378-1097(94)90267-4 · Cited by 593
Macrolide Resistance Conferred by Base Substitutions in 23S rRNA
Vester, B., & Douthwaite, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.1-12.2001 · Cited by 556
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Molecular Genetics of Mycobacteria
(2014) · ASM Press eBooks · doi:10.1128/9781555818845 · Cited by 429
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
DeBarber, A. E., Mdluli, K., Bosman, M., Bekker, L.-G., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9677 · Cited by 338
Mitchison, D. A., & Nunn, A. (1986) · PubMed · doi:10.1164/arrd.1986.133.3.423 · Cited by 291
Zhang, Y., Scorpio, A., Nikaido, H., & Sun, Z. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.7.2044-2049.1999 · Cited by 285
Vilchèze, C., Morbidoni, H. R., Weisbrod, T. R., Iwamoto, H., Kuo, M., Sacchettini, J. C., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.4059-4067.2000 · Cited by 283
Johnsson, K., & Schultz, P. G. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00095a063 · Cited by 278
Zimhony, O., Cox, J. S., Welch, J. T., Vilchèze, C., & Jacobs, W. R. (2000) · Nature Medicine · doi:10.1038/79558 · Cited by 270
Heym, B., Honoré, N., Schurra, C., Cole, S. T., Heym, B., Truffot-Pernot, C., Grosset, J. H., Banerjee, A., Jacobs, W. R., & van Embden, J. D. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91338-2 · Cited by 263
Maldhure, B. R., Munje, R. P., Zodpey, S. P., et al. (1997) · Lung India · Cited by 260
Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Kramer, F. R., & Alland, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.103-110.2000 · Cited by 218
Rouse, D. A., DeVito, J. A., Li, Z., Byer, H., & Morris, S. L. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.00133.x · Cited by 158
Marttila, H., Soini, H., Eerola, E., Vyshnevskaya, E. B., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., & Viljanen, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2443 · Cited by 158
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.69.3.471 · Cited by 157
Slayden, R. A., Lee, R. E., Jr., & Barry, C. E. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02145.x · Cited by 153
Heep, M., Rieger, U., Beck, D., & Lehn, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1075-1077.2000 · Cited by 153
Ohno, H., Koga, H., KOHNO, S., Tashiro, T., & Hara, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.1053 · Cited by 149
Yang, B., Koga, H., Ohno, H., Ogawa, K., Fukuda, M., Hirakata, Y., Maesaki, S., Tomono, K., Tashiro, T., & Kohno, S. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.5.621 · Cited by 148
The sterilizing value of rifampicin and pyrazinamide in experimental short course chemotherapy
Grosset, J. H. E. (1978) · Tubercle · doi:10.1016/0041-3879(78)90007-7 · Cited by 135
Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A., & Wong, S. Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2087 · Cited by 127
Wilson, T. M., de Lisle, G. W., Marcinkeviciene, J. A., Blanchardand, J. S., & Collins, D. M. (1998) · Microbiology · doi:10.1099/00221287-144-10-2687 · Cited by 105
Mycobacterium tuberculosis Cell Envelope
Lee, R. E., Jr., Brennan, P. J., & Besra, G. S. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80166-2_1 · Cited by 103
Schwoebel, V., Weezenbeek, C. S. B. L.-V., Moro, M. L., Drobniewski, F. A., Hoffner, S. E., Raviglione, M. C., & Rieder, H. L. (2000) · European Respiratory Journal · doi:10.1183/09031936.00.16236400 · Cited by 97
Understanding the chemotherapy of tuberculosis—current problems
MITCHISON, D. A. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.5.477 · Cited by 91
DRUG RESISTANCE IN TUBERCULOSIS
Parsons, L. M., Driscoll, J. R., Taber, H. W., & Salfinger, M. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70397-4 · Cited by 46
Self-citationAccess to newer laboratory procedures: a call for action.
Hale, Y. M., Desmond, E., Jost, K. C., Jr., et al. (2000) · PubMed · Cited by 13
Cited by
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Alsultan, A., & Peloquin, C. A. (2014) · Drugs · doi:10.1007/s40265-014-0222-8 · Cited by 444
The genetic basis of the fitness costs of antimicrobial resistance: a meta‐analysis approach
Vogwill, T., & MacLean, R. C. (2015) · Evolutionary Applications · doi:10.1111/eva.12202 · Cited by 443
Dookie, N., Rambaran, S., Padayatchi, N., Mahomed, S., & Naidoo, K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx506 · Cited by 346
Metadata
- Authors
- Somoskovi, A., Parsons, L. M., & Salfinger, M.
- Venue
- Respiratory Research
- Published
- 2001-04-05
- Volume
- 2
- Issue
- 3
- Pages
- 164-8
- ISSN
- 1465-9921 (ISSN-L)
- 1465-993X
- DOI
- 10.1186/rr54
- OpenAlex
- W2130610060
- Cited by
- 373
- References
- 34
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
